Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma

Clinical and Experimental Metastasis

Volumn 19, Issue 7, 2002, Pages 583-591

  Asosingh, Kewal ^a   Menu, Eline ^a   Van Valckenborgh, Els ^a   Vande Broek, Isabelle ^a   Van Riet, Ivan ^a   Van Camp, Ben ^a   Vanderkerken, Karin ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Adhesion; Bone marrow; CD45; Homing; Invasion; Migration; Myeloma

Indexed keywords

CD45 ANTIGEN; EPIGALLOCATECHIN GALLATE; GELATINASE B; LAMININ 1; PROTEINASE; SCLEROPROTEIN; UROKINASE; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; BONE MARROW CELL; CANCER INVASION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; IN VIVO STUDY; ISOTOPE LABELING; LYMPHOCYTE SUBPOPULATION; MELANOMA CELL; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; STROMA CELL; ZYMOGRAPHY;

ANIMALS; ANTIGENS, CD45; BONE MARROW; CATECHIN; CELL ADHESION; CELLS, CULTURED; CHEMOTAXIS; ENDOTHELIUM; FIBROBLASTS; LAMININ; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MULTIPLE MYELOMA; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; PROTEASE INHIBITORS; RECEPTORS, CELL SURFACE; T-LYMPHOCYTE SUBSETS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036459199     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020987830132     Document Type: Article

References (30)

1. Vanderkerken K, De Greef C, Asosingh K et al. Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse. Br J Cancer 2000; 82: 953-59.
2. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 60-6.
3. Vanderkerken K, Asosingh K, Braet F et al. Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells. Blood 1999; 93: 235-41.
4. Asosingh K, Gunthert U, Bakkus MH et al. In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. Cancer Res 2000; 60: 3096-104.
5. Asosingh K, Gunthert U, De Raeve H et al. A unique pathway in the homing of murine multiple myeloma cells: CD44v10 mediates binding to bone marrow endothelium. Cancer Res 2001; 61: 2862-5.
6. Asosingh K, Radl J, Van Riet I et al. The 5TMM series: A useful in vivo mouse model of human multiple myeloma. Hematol J 2000; 1: 351-6.
7. Radl J, De Glopper ED, Schuit HR et al. Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol 1979; 122: 609-13.
8. Radl J, Croese JW, Zurcher C et al. Animal model of human disease. Multiple myeloma. Am J Pathol 1988; 132: 593-7.
9. Vanderkerken K, De Raeve H, Goes E et al. Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer 1997; 76: 451-60.
10. Van Valckenborgh E. De Raeve H, Devy L et al. Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. Br J Cancer 2002; 86: 796-802.
11. Jensen GS, Poppema S, Mant MJ et al. Transition in CD45 isoform expression during differentiation of normal and abnormal B cells. Int Immunol 1989; 1: 229-36.
12. +) 5T multiple myeloma cells. Exp Hematol 2001; 29: 77-84.
13. Gardsvoll H, Solberg H, Dano K et al. Generation of high-affinity rabbit polyclonal antibodies to the murine urokinase receptor using DNA immunization. J Immunol Methods 2000; 234: 107-16.
14. Garbisa S, Sartor L, Biggin S et al. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 2001; 91: 822-32.
15. Vanderkerken K, Vande Broek I, Eizerik DL et al. Monocyte chemoattractant-I (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of multiple myeloma cells. Clin Exp Metastasis 2002; 19: 87-90.
16. Vracko R. Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am J Pathol 1974; 77: 314-46.
17. Vande Broek I, Vanderkerken K, De Greef C et al. The high affinity 67 kD laminin receptor is expressed by multiple myeloma cells and mediates cell migration. Br J Cancer 2002; 85: 1387-95.
18. Stetler-Stevenson WG, Liotta LA, Kleiner DE, Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. Faseb J 1993; 7: 1434-41.
19. Noel A, Gilles C, Bajou K et al. Emerging roles for proteinases in cancer. Invasion Metastasis 1997; 17: 221-39.
20. Liotta LA, Tryggvason K, Garbisa S et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
21. Liotta LA. Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986; 46: 1-7.
22. Nykjaer A, Conese M, Christensen EI et al. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. Embo J 1997; 16: 2610-20.
23. Hjertner O, Qvigstad G, Hjorth-Hansen H et al. Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells. Br J Haematol 2000; 109: 815-22.
24. Dhodapkar M V Sanderson RD. Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: A multifunctional regulator of cell behavior within the tumor microenvironment. Leuk Lymph 1999; 34: 35-43.
25. Himelstein BP., Canete-Soler R, Bernhard EJ et al. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 1994; 14: 246-58.
26. John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7: 14-23.
27. Vanderkerken K, Van Valckenborg E, Bakkus M et al. Bone marrow microenvironmental-induced upregulation of MMP-9 activity in murine multiple myeloma cells. Clin Exp Metastasis 2000; 17: 766 (abstract).
28. Vacca A, Ribatti D, Presta M et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93; 3064-73.
29. Barillé S, Bataille R, Rapp MJ et al. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J Immunol 1999; 163: 5723-8.
30. Kaushal GP, Xiong X, Athota AB et al. Syndecan-1 expression suppresses the level of myeloma matrix metalloproteinase-9. Br J Haematol 1999; 104: 365-73.